Group14 Technologies
Series B in 2020
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.
Group14 Technologies
Series A in 2019
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.
Adapx
Venture Round in 2013
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.
EnerG2
Venture Round in 2013
EnerG2, Inc. is a manufacturer of engineered carbon materials based in Seattle, Washington, with an additional facility in Albany, Oregon. Founded in 2003, the company specializes in producing advanced nano-structured carbon materials tailored for energy storage applications. EnerG2's proprietary manufacturing technologies enable the development of high-performance materials that exceed the capabilities of naturally occurring carbons. These materials are designed to enhance power density and cycle life in a range of energy storage devices, including ultracapacitors, lead-acid batteries, and lithium-ion batteries. By focusing on customized electrode materials, EnerG2 aims to improve charge acceptance and device longevity, thereby advancing the efficiency and effectiveness of energy storage solutions.
NanoString Technologies
Series E in 2012
NanoString Technologies provides life science tools for translational research and molecular diagnostics. It offers the nCounter Analysis System, featuring automated liquid handling and digital detection, along with customizable assays and software for data analysis. The company also develops spatial genomics systems like GeoMx DSP and Hyb & Seq. Its products enable various applications in basic research, translational medicine, and diagnostics.
Adapx
Venture Round in 2012
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.
NanoString Technologies
Series D in 2011
NanoString Technologies provides life science tools for translational research and molecular diagnostics. It offers the nCounter Analysis System, featuring automated liquid handling and digital detection, along with customizable assays and software for data analysis. The company also develops spatial genomics systems like GeoMx DSP and Hyb & Seq. Its products enable various applications in basic research, translational medicine, and diagnostics.
Oncofactor
Series A in 2011
Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
PrecisionDemand
Series C in 2011
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.
Adapx
Venture Round in 2011
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.
PrecisionDemand
Series B in 2010
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.
PrecisionDemand
Series B in 2009
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.
EnerG2, Inc. is a manufacturer of engineered carbon materials based in Seattle, Washington, with an additional facility in Albany, Oregon. Founded in 2003, the company specializes in producing advanced nano-structured carbon materials tailored for energy storage applications. EnerG2's proprietary manufacturing technologies enable the development of high-performance materials that exceed the capabilities of naturally occurring carbons. These materials are designed to enhance power density and cycle life in a range of energy storage devices, including ultracapacitors, lead-acid batteries, and lithium-ion batteries. By focusing on customized electrode materials, EnerG2 aims to improve charge acceptance and device longevity, thereby advancing the efficiency and effectiveness of energy storage solutions.
DepotPoint
Series C in 2008
DepotPoint is a software company that specializes in the distressed property market, emphasizing transparency, efficiency, and intelligence in its solutions. Founded in 2005 and headquartered in Bellevue, Washington, DepotPoint develops web-based platforms tailored for the real estate foreclosure sector in the United States. Its primary offerings include the TrackPoint Platform, which enables users to manage property files throughout the default process, and ForeclosurePoint, a marketing platform designed to provide resources for real estate professionals and buyers dealing with distressed properties.
PrecisionDemand
Series A in 2008
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.
AdmitOne Security
Series C in 2008
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.
Allozyne, Inc. is a biopharmaceutical company focused on developing novel protein therapeutic product candidates aimed at treating autoimmune and inflammatory diseases, as well as cancer. Founded in 2004 and headquartered in Seattle, Washington, Allozyne is known for its lead product candidate, AZ01, which is currently in Phase 1b clinical trials for relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody targeting various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate designed for treating solid tumors. Additionally, Allozyne specializes in the development of technologies that enhance the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. The company operates as a subsidiary of Poniard Pharmaceuticals, Inc.
Accelerator Corp.
Series C in 2007
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.
NanoString Technologies
Series B in 2007
NanoString Technologies provides life science tools for translational research and molecular diagnostics. It offers the nCounter Analysis System, featuring automated liquid handling and digital detection, along with customizable assays and software for data analysis. The company also develops spatial genomics systems like GeoMx DSP and Hyb & Seq. Its products enable various applications in basic research, translational medicine, and diagnostics.
AdmitOne Security
Series C in 2007
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.
Allozyne, Inc. is a biopharmaceutical company focused on developing novel protein therapeutic product candidates aimed at treating autoimmune and inflammatory diseases, as well as cancer. Founded in 2004 and headquartered in Seattle, Washington, Allozyne is known for its lead product candidate, AZ01, which is currently in Phase 1b clinical trials for relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody targeting various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate designed for treating solid tumors. Additionally, Allozyne specializes in the development of technologies that enhance the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. The company operates as a subsidiary of Poniard Pharmaceuticals, Inc.
Scout Analytics
Series B in 2005
Scout Analytics is a leader in digital revenue optimization, specializing in enhancing the average revenue per user for publishers by 10-15 percent. The company offers a cloud-based recurring revenue management platform that transforms usage data into predictive analytics, allowing publishers to effectively analyze subscription usage, spending, and trial conversions. Their SaaS application utilizes patent-pending behavioral analytics technology to target and monetize user engagement, making it a valuable tool for both subscription and advertising revenue models. With a presence in over 70 publishing organizations, Scout Analytics provides solutions to reduce customer churn, increase renewal revenue, optimize rate plan performance, and maximize trial conversions. Headquartered in Issaquah, Washington, Scout Analytics is a venture-backed company committed to driving revenue growth for its clients.
AdmitOne Security
Series B in 2005
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.
Integrated Diagnostics
Series A in 2005
Integrated Diagnostics Inc. is a company focused on developing laboratory-based blood diagnostic tools that facilitate the early diagnosis of complex diseases through non-invasive blood tests. Established in 2005 and headquartered in Seattle, Washington, the company specializes in products that monitor multiple molecular markers simultaneously, offering valuable insights for conditions such as lung cancer. One of its key offerings is Xpresys Lung, a molecular blood test designed to provide objective information for assessing pulmonary nodules. Integrated Diagnostics is committed to leveraging advanced technologies to create a pipeline of innovative diagnostic products aimed at enhancing disease management for conditions including cancer, diabetes, and Alzheimer's. The company operates under a strategic partnership with Agilent Technologies Inc. and has been functioning as a subsidiary of Biodesix, Inc. since 2018.
NanoString Technologies
Series A in 2005
NanoString Technologies provides life science tools for translational research and molecular diagnostics. It offers the nCounter Analysis System, featuring automated liquid handling and digital detection, along with customizable assays and software for data analysis. The company also develops spatial genomics systems like GeoMx DSP and Hyb & Seq. Its products enable various applications in basic research, translational medicine, and diagnostics.
Accelerator Corp.
Venture Round in 2004
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.